vs
Side-by-side financial comparison of ALCON INC (ALC) and CME Group (CME). Click either name above to swap in a different company.
ALCON INC is the larger business by last-quarter revenue ($2.6B vs $1.9B, roughly 1.4× CME Group). ALCON INC runs the higher net margin — 6.8% vs 0.1%, a 6.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 4.0%).
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...
ALC vs CME — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.6B | $1.9B |
| Net Profit | $176.0M | $1.2M |
| Gross Margin | 53.5% | — |
| Operating Margin | 9.5% | 0.1% |
| Net Margin | 6.8% | 0.1% |
| Revenue YoY | 4.0% | 14.5% |
| Net Profit YoY | -21.1% | 20.7% |
| EPS (diluted) | $0.35 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.9B | ||
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $2.6B | $1.7B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $2.5B | $1.5B |
| Q1 26 | — | $1.2M | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $908.0M | ||
| Q2 25 | $176.0M | $1.0B | ||
| Q1 25 | — | $956.2M | ||
| Q4 24 | — | $874.6M | ||
| Q3 24 | — | $912.8M | ||
| Q2 24 | $223.0M | $883.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 55.0% | — |
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 63.3% | ||
| Q2 25 | 9.5% | 66.7% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 62.1% | ||
| Q3 24 | — | 64.6% | ||
| Q2 24 | 12.7% | 65.3% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | 71.7% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | 6.8% | 60.6% | ||
| Q1 25 | — | 58.2% | ||
| Q4 24 | — | 57.3% | ||
| Q3 24 | — | 57.6% | ||
| Q2 24 | 8.9% | 57.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.24 | ||
| Q3 25 | — | $2.49 | ||
| Q2 25 | $0.35 | $2.81 | ||
| Q1 25 | — | $2.62 | ||
| Q4 24 | — | $2.40 | ||
| Q3 24 | — | $2.50 | ||
| Q2 24 | $0.45 | $2.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $2.4B |
| Total DebtLower is stronger | — | $3.4B |
| Stockholders' EquityBook value | $22.1B | — |
| Total Assets | $31.4B | $202.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.4B | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | $1.4B | $2.1B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | $1.4B | $1.9B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $28.7B | ||
| Q3 25 | — | $28.2B | ||
| Q2 25 | $22.1B | $27.7B | ||
| Q1 25 | — | $27.0B | ||
| Q4 24 | — | $26.5B | ||
| Q3 24 | — | $28.2B | ||
| Q2 24 | $20.9B | $27.6B |
| Q1 26 | — | $202.0B | ||
| Q4 25 | — | $198.4B | ||
| Q3 25 | — | $187.1B | ||
| Q2 25 | $31.4B | $179.9B | ||
| Q1 25 | — | $157.8B | ||
| Q4 24 | — | $137.4B | ||
| Q3 24 | — | $137.8B | ||
| Q2 24 | $29.7B | $123.4B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
